Canada markets open in 7 hours 17 minutes

Paratek Pharmaceuticals, Inc. (PRTK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.4700+0.0400 (+0.90%)
At close: 04:00PM EST
4.4700 0.00 (0.00%)
After hours: 05:39PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close4.4300
Open4.3900
Bid0.0000 x 900
Ask0.0000 x 900
Day's Range4.2500 - 4.5300
52 Week Range4.0300 - 11.2400
Volume293,058
Avg. Volume280,580
Market Cap224.344M
Beta (5Y Monthly)1.47
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateOct. 31, 2014
1y Target EstN/A
All
News
  • GlobeNewswire

    Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

    BOSTON, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use, today announced that on December 31, 2021, the Company granted stock options and restricted stock units to two new employees of the Company. These awards were granted pursuant to the

  • GlobeNewswire

    China's National Medical Products Administration Approves NUZYRA® (omadacycline) for the Treatment of Bacterial Pneumonia and Skin Infections

    Paratek earns $6 million milestone payment from Zai LabBOSTON, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company’s partner in China, Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), received approval from the National Medical Products Administration (NMPA) of China of NUZYRA® (omadacycline) for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). Paratek commerciall

  • GlobeNewswire

    Paratek Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference

    BOSTON, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that Evan Loh, chief executive officer, will present at the 2021 Jefferies London Healthcare Conference. The on-demand presentation will be available Thursday, Nov. 18 beginning at 3 a.m. EST through Friday, Nov. 19 at 12 p.m. EST. To access the webcast, please visit: https://wsw.meetmax.com/admin/presenterlinks/?436013913&group=TbkBHEif. A replay of the webcast can be accessed for up to 30 day